title: Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses.
abstract: We used recombinant vaccinia viruses (rVV) containing the UL97 open reading frame (ORF) of the human cytomegalovirus (HCMV) to investigate the UL97-dependent phosphorylation of different nucleoside analogs. The rVV T1 expressed the wild-type UL97 protein whereas rVV A5 contained a 12 bp deletion in the UL97 which had been known to be responsible for resistance of HCMV to ganciclovir (GCV). The rVV T1opal was generated which contained a stop codon at position 1089 of the UL97 ORF and which expressed a truncated UL97 protein. We quantitatively analyzed the capability of these rVVs to phosphorylate GCV, penciclovir (PCV), aciclovir (ACV) and 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl] purine (S2242) as well as the natural nucleosides deoxycytidine and deoxythymidine. Moreover, we compared their phosphorylating capability with that of herpes simplex virus type 1 strains. In thymidine kinase (TK)-deficient 143B cells infected with rVV T1, the three compounds GCV, ACV and PCV were phosphorylated with different efficiency whereas in cells infected with the rVV A5 a markedly reduced but not completely abolished phosphorylation of these compounds was observed. In rVV T1opal-infected cells no specific phosphorylation of the compounds was detectable at all. Neither S2242 nor the natural substrates of TKs were phosphorylated by any of the vaccinia recombinants. The rVVs proved to be a suitable tool for analysis of UL97-dependent phosphorylation of nucleoside analogs and also allowed to quantitatively study the influence of UL97 mutations on drug phosphorylation.
authors.affiliation: Universität Ulm, Abteilung Virologie, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Zimmermann
authors.forename: D
authors.initials: D
authors.lastname: Michel
authors.forename: I
authors.initials: I
authors.lastname: Pavić
authors.forename: W
authors.initials: W
authors.lastname: Hampl
authors.forename: A
authors.initials: A
authors.lastname: Lüske
authors.forename: J
authors.initials: J
authors.lastname: Neyts
authors.forename: E
authors.initials: E
authors.lastname: De Clercq
authors.forename: T
authors.initials: T
authors.lastname: Mertens
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives* / Q000378:metabolism*; D000998:Antiviral Agents / Q000378:metabolism; D002478:Cells, Cultured; D015774:Ganciclovir / Q000378:metabolism*; D006147:Guanine; D006801:Humans; D010766:Phosphorylation; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism*; D011687:Purines / Q000378:metabolism*; D011995:Recombination, Genetic; D014616:Vaccinia virus / Q000235:genetics
chemical_list: D000998:Antiviral Agents; D011687:Purines; C092709:S 2242; C053539:penciclovir; D006147:Guanine; D017853:Phosphotransferases (Alcohol Group Acceptor); C075365:ganciclovir kinase; D015774:Ganciclovir; D000212:Acyclovir